metoprolol has been researched along with Hypokalemic Periodic Paralysis in 1 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Hypokalemic Periodic Paralysis: An autosomal dominant familial disorder characterized by recurrent episodes of skeletal muscle weakness associated with falls in serum potassium levels. The condition usually presents in the first or second decade of life with attacks of trunk and leg paresis during sleep or shortly after awakening. Symptoms may persist for hours to days and generally are precipitated by exercise or a meal high in carbohydrates. (Adams et al., Principles of Neurology, 6th ed, p1483)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zayac, A | 1 |
| Shah, R | 1 |
| Shah, M | 1 |
| Umar, J | 1 |
| Bansal, N | 1 |
| Dhamoon, A | 1 |
1 other study available for metoprolol and Hypokalemic Periodic Paralysis
| Article | Year |
|---|---|
Thyrotoxic hypokalemic periodic paralysis.
Topics: Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Humans; Hypokalemic Periodic Paralysis; Male; Met | 2016 |